Kyla Ortved

34PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersParticle physicsBiomechanicsProteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 07, 2026
Melatonin differentially modulates chondro-osteogenic lineage commitment and suppresses proinflammatory mediator production in equine mesenchymal stem cells.

|Jul 29, 2026
The in vitro application of high-intensity laser therapy on equine platelet-rich plasma and autologous protein solution does not alter select cytokine and growth factor concentrations.

|Jul 29, 2026
Evaluation of Microvascular Flow Imaging and Power Doppler Ultrasonography in an Equine Model of Induced Superficial Digital Flexor Tendonitis.

|Jun 10, 2026
Single-dose intravenous α2-agonists do not acutely alter anti-inflammatory bioactive protein profiles but reduce interleukin-8 in equine autologous protein solution and platelet-rich plasma.

|Mar 06, 2026
Equine autologous platelet concentrate is a leukocyte-rich platelet-rich plasma with a high interleukin-1Ra-to-interleukin-1β ratio and high transforming growth factor-β1 concentration.

Katlyn D McKenna, Sarah E Struble, Luma N F Max

|Oct 27, 2025
Modeling chondrocyte/synoviocyte inflammation: a comparative approach to recombinant interleukin-10 treatment strategies and their functional differences.

Hoda A Elkhenany, Renata L Linardi, Kyla F Ortved

Pageof 6

Frequent Collaborators

5 joint publications

Darko Stefanovski

5 joint publications

Kathryn Wulster

2 joint publications

Alexandra L Curtiss

2 joint publications

Virginia Melly